Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Scholar Rock Holding Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 166
- +6 vs. Q1 2024
- Shares held
- 85.5M
- +738.6K (+0.9%) vs. Q1 2024
- Total value
- $712.1M
- −$792.8M (−52.7%) vs. Q1 2024
- New holders
- 33
- 69 more added
- Sold out
- 27
- 45 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRRK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 306 | $7.63B |
| Q1 2026 | 274 | $6.53B |
| Q4 2025 | 274 | $5.44B |
| Q3 2025 | 241 | $4.32B |
| Q2 2025 | 236 | $3.89B |
| Q1 2025 | 231 | $3.42B |
| Q4 2024 | 224 | $4.51B |
| Q3 2024 | 161 | $710.2M |
| Q2 2024 | 166 | $712.1M |
| Q1 2024 | 161 | $1.51B |
| Q4 2023 | 133 | $1.52B |
| Q3 2023 | 89 | $382.7M |
| Q2 2023 | 85 | $386.3M |
| Q1 2023 | 87 | $374.1M |
| Q4 2022 | 82 | $410.2M |
| Q3 2022 | 85 | $313.1M |
| Q2 2022 | 83 | $248.6M |
| Q1 2022 | 94 | $402.2M |
| Q4 2021 | 90 | $738.8M |
| Q3 2021 | 101 | $952.5M |
| Q2 2021 | 105 | $825.5M |
| Q1 2021 | 124 | $1.41B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Scholar Rock Holding Corp; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 11,259,438 | $93.8M | 2.41% | 00.0% | Unchanged |
| FMR LLC | 9,887,233 | $82.4M | 0.01% | −715,144−6.7% | Reduced |
| Price T Rowe Associates Inc | 8,188,127 | $68.2M | 0.01% | −19,986−0.2% | Reduced |
| Samsara BioCapital, LLC | 6,788,609 | $56.5M | 11.84% | 00.0% | Unchanged |
| BlackRock Inc. | 5,664,419 | $47.2M | 0.00% | +658,535+13.2% | Added |
| Redmile Group, LLC | 5,453,083 | $45.4M | 2.75% | −966,527−15.1% | Reduced |
| Vanguard Group Inc | 3,836,560 | $32.0M | 0.00% | +867,026+29.2% | Added |
| Eventide Asset Management, LLC | 3,074,475 | $25.6M | 0.44% | +1,561,195+103.2% | Added |
| Polar Capital Holdings Plc | 2,940,672 | $24.5M | 0.14% | 00.0% | Unchanged |
| State Street Corp | 2,808,924 | $23.4M | 0.00% | −1,360,846−32.6% | Reduced |
| Bellevue Group AG | 2,165,203 | $18.0M | 0.29% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,422,536 | $11.9M | 0.00% | +231,280+19.4% | Added |
| Goldman Sachs Group Inc | 1,339,081 | $11.2M | 0.00% | +106,935+8.7% | Added |
| OrbiMed Advisors LLC | 1,074,382 | $8.95M | 0.19% | −2,500,250−69.9% | Reduced |
| MPM Oncology Impact Management LP | 1,028,330 | $8.57M | 1.33% | +1,028,330 | New |
| Millennium Management LLC | 925,584 | $7.71M | 0.01% | +568,512+159.2% | Added |
| Hood River Capital Management LLC | 832,792 | $6.94M | 0.14% | +40,745+5.1% | Added |
| Two Sigma Investments, LP | 800,672 | $6.67M | 0.02% | +479,853+149.6% | Added |
| Clearbridge Investments, LLC | 747,105 | $6.22M | 0.01% | +747,105 | New |
| Candriam Luxembourg S.C.A. | 744,443 | $6.20M | 0.04% | +744,443 | New |
| Woodline Partners LP | 708,187 | $5.90M | 0.06% | −353,563−33.3% | Reduced |
| Two Sigma Advisers, LP | 590,800 | $4.92M | 0.01% | +562,000+1,951.4% | Added |
| Standard Life Aberdeen plc | 583,774 | $4.86M | 0.01% | +414,777+245.4% | Added |
| BIT Capital GmbH | 528,288 | $4.40M | 0.40% | +46,526+9.7% | Added |
| Northern Trust Corp | 505,224 | $4.21M | 0.00% | −10,618−2.1% | Reduced |
| Marshall Wace, LLP | 487,285 | $4.06M | 0.01% | +444,961+1,051.3% | Added |
| Charles Schwab Investment Management Inc | 460,654 | $3.84M | 0.00% | +58,173+14.5% | Added |
| Cubist Systematic Strategies, LLC | 439,557 | $3.66M | 0.06% | +264,581+151.2% | Added |
| UBS Group AG | 425,312 | $3.54M | 0.00% | −7,147−1.7% | Reduced |
| Integral Health Asset Management, LLC | 400,000 | $3.33M | 0.33% | +75,000+23.1% | Added |
| Ameriprise Financial Inc | 381,025 | $3.17M | 0.00% | −8,470−2.2% | Reduced |
| Deep Track Capital, LP | 372,559 | $3.10M | 0.09% | −307,441−45.2% | Reduced |
| AXA S.A. | 372,250 | $3.10M | 0.01% | +207+0.1% | Added |
| Balyasny Asset Management LLC | 366,078 | $3.05M | 0.01% | −196,141−34.9% | Reduced |
| TD Asset Management Inc | 309,646 | $2.58M | 0.00% | 00.0% | Unchanged |
| Kennedy Capital Management, Inc. | 279,951 | $2.33M | 0.05% | +4,057+1.5% | Added |
| Trexquant Investment LP | 272,795 | $2.27M | 0.03% | +134,723+97.6% | Added |
| Citigroup Inc | 269,281 | $2.24M | 0.00% | −267,048−49.8% | Reduced |
| D. E. Shaw & Co., Inc. | 254,039 | $2.12M | 0.00% | +142,173+127.1% | Added |
| Bank of America Corp | 253,527 | $2.11M | 0.00% | +14,780+6.2% | Added |
| Dimensional Fund Advisors LP | 248,736 | $2.07M | 0.00% | −40,499−14.0% | Reduced |
| Morgan Stanley | 247,567 | $2.06M | 0.00% | −9,888−3.8% | Reduced |
| Bank of New York Mellon Corp | 230,450 | $1.92M | 0.00% | +33,468+17.0% | Added |
| Qube Research & Technologies Ltd | 225,145 | $1.88M | 0.00% | +191,788+575.0% | Added |
| Manufacturers Life Insurance Company, The | 222,800 | $1.86M | 0.00% | +52,329+30.7% | Added |
| Laurion Capital Management LP | 214,972 | $1.79M | 0.06% | −310,084−59.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 207,491 | $1.73M | 0.01% | +68,427+49.2% | Added |
| Nuveen Asset Management, LLC | 195,119 | $1.63M | 0.00% | −87,617−31.0% | Reduced |
| Ikarian Capital, LLC | 183,701 | $1.53M | 0.48% | −108,000−37.0% | Reduced |
| Wellington Management Group LLP | 171,976 | $1.43M | 0.00% | +14,695+9.3% | Added |
| J. Goldman & Co LP | 171,094 | $1.43M | 0.05% | +72,706+73.9% | Added |
| Jane Street Group, LLC | 155,788 | $1.30M | 0.00% | −88,530−36.2% | Reduced |
| Squarepoint Ops LLC | 145,060 | $1.21M | 0.00% | +134,621+1,289.6% | Added |
| Jennison Associates LLC | 140,776 | $1.17M | 0.00% | +2,318+1.7% | Added |
| Rafferty Asset Management, LLC | 132,991 | $1.11M | 0.00% | −212,771−61.5% | Reduced |
| Adage Capital Partners GP, L.L.C. | 125,000 | $1.04M | 0.00% | −400,000−76.2% | Reduced |
| Canada Pension Plan Investment Board | 120,000 | $999.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 112,996 | $941.3K | 0.00% | −531,793−82.5% | Reduced |
| Fisher Asset Management, LLC | 105,833 | $881.6K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 101,278 | $843.6K | 0.00% | +7,222+7.7% | Added |
| Jump Financial, LLC | 95,590 | $796.3K | 0.02% | +48,955+105.0% | Added |
| Renaissance Technologies LLC | 92,364 | $769.4K | 0.00% | +92,364 | New |
| E. Ohman J:or Asset Management AB | 92,000 | $766.4K | 0.02% | +92,000 | New |
| UBS Asset Management Americas Inc | 88,526 | $737.4K | 0.00% | +27,907+46.0% | Added |
| Swiss National Bank | 84,200 | $701.4K | 0.00% | +5,900+7.5% | Added |
| Voloridge Investment Management, LLC | 84,037 | $700.0K | 0.00% | +71,155+552.4% | Added |
| Barclays PLC | 81,331 | $677.5K | 0.00% | +1,230+1.5% | Added |
| Atom Investors LP | 77,515 | $645.7K | 0.06% | +67,423+668.1% | Added |
| First Trust Advisors LP | 76,347 | $636.0K | 0.00% | +76,347 | New |
| Walleye Capital LLC | 74,292 | $618.9K | 0.01% | +74,292 | New |
| Raymond James & Associates | 68,478 | $570.4K | 0.00% | +54,887+403.8% | Added |
| Quest Partners LLC | 61,029 | $508.4K | 0.07% | +52,660+629.2% | Added |
| ClariVest Asset Management LLC | 59,640 | $496.8K | 0.05% | +1,718+3.0% | Added |
| Gsa Capital Partners LLP | 58,870 | $490.0K | 0.03% | +58,870 | New |
| Exchange Traded Concepts, LLC | 58,222 | $485.0K | 0.01% | +58,222 | New |
| Alliancebernstein L.P. | 56,870 | $473.7K | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 56,850 | $473.6K | 0.08% | +56,850 | New |
| Boothbay Fund Management, LLC | 48,846 | $406.9K | 0.01% | −28,717−37.0% | Reduced |
| EntryPoint Capital, LLC | 48,826 | $406.7K | 0.19% | +48,826 | New |
| Polar Asset Management Partners Inc. | 48,600 | $404.8K | 0.01% | +6,300+14.9% | Added |
| Legal & General Group Plc | 47,797 | $398.2K | 0.00% | +2,685+6.0% | Added |
| Rice Hall James & Associates, LLC | 46,000 | $383.2K | 0.02% | +1,594+3.6% | Added |
| Voya Investment Management LLC | 45,492 | $378.9K | 0.00% | −71,636−61.2% | Reduced |
| California State Teachers Retirement System | 43,808 | $364.9K | 0.00% | +2,337+5.6% | Added |
| Graham Capital Management, L.P. | 41,410 | $344.9K | 0.01% | +12,141+41.5% | Added |
| Cinctive Capital Management LP | 40,033 | $333.5K | 0.02% | −8,302−17.2% | Reduced |
| MetLife Investment Management | 39,966 | $332.9K | 0.00% | +10,642+36.3% | Added |
| AQR Capital Management LLC | 39,754 | $331.1K | 0.00% | +29,487+287.2% | Added |
| Tudor Investment Corp Et Al | 39,713 | $330.8K | 0.00% | +18,847+90.3% | Added |
| Ensign Peak Advisors, Inc | 38,974 | $324.7K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 38,347 | $319.4K | 0.00% | +433+1.1% | Added |
| Engineers Gate Manager LP | 37,924 | $315.9K | 0.01% | +11,506+43.6% | Added |
| LPL Financial LLC | 37,667 | $313.8K | 0.00% | +16,938+81.7% | Added |
| DekaBank Deutsche Girozentrale | 38,000 | $307.0K | 0.00% | 00.0% | Unchanged |
| Corebridge Financial, Inc. | 36,851 | $307.0K | 0.00% | +36,851 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 34,293 | $285.8K | 0.00% | +34,293 | New |
| Jasper Ridge Partners, L.P. | 31,568 | $263.0K | 0.01% | +7,963+33.7% | Added |
| Walleye Trading LLC | 30,096 | $250.7K | 0.00% | +20,096+201.0% | Added |
| Deutsche Bank AG | 29,881 | $248.9K | 0.00% | +165+0.6% | Added |
| Dynamic Technology Lab Private Ltd | 28,444 | $237.0K | 0.03% | +14,816+108.7% | Added |